Which pathway addresses loss of strength?
Loss of strength is routed by hormonal context. Men with confirmed low testosterone → TRT. Peri/menopausal women → BHRT. Documented GH-axis decline → sermorelin. Resistance training and protein are foundational.
Full answer
Strength loss is screened against training stimulus, protein intake, sleep, and hormonal context. Resistance training (progressive overload) and protein (≥1.6 g/kg) remain foundational. Men with confirmed low total/free testosterone whose strength and recovery match are evaluated for Testosterone Optimization. Peri/menopausal women with matching biomarkers are evaluated for BHRT, sometimes including low-dose testosterone. Candidates with documented GH-axis decline are evaluated for sermorelin. Every initiation is synchronous-video reviewed.
Educational. Not a substitute for individualized provider review.
- Testosterone Optimization pathway — Primary source · oMeds
- Reviewed by Dr. Laura Purdy, MD, MBA · Clinical Director, oMeds · Last reviewed 2026-05-29